BindingDB logo
myBDB logout

BDBM50262697 CHEMBL4088140

SMILES: Cl.Cl.NC(=N)Nc1ccc(CCc2cnc(nc2)N2CCOCC2)cc1

InChI Key: InChIKey=AIEYWUKMZLPZDJ-UHFFFAOYSA-N

Data: 1 IC50

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50262697   
Target/Host
(Institution)		LigandTarget/Host
Links		Ligand
Links		Trg + Lig
Links		Ki
nM		ΔG°
kcal/mole		IC50
nM		Kd
nM		EC50/IC50
nM		koff
s-1		kon
M-1s-1		pHTemp
°C
Membrane primary amine oxidase


(Homo sapiens (Human))		BDBM50262697
PNG
(CHEMBL4088140)
Show SMILES Cl.Cl.NC(=N)Nc1ccc(CCc2cnc(nc2)N2CCOCC2)cc1
Show InChI InChI=1S/C17H22N6O/c18-16(19)22-15-5-3-13(4-6-15)1-2-14-11-20-17(21-12-14)23-7-9-24-10-8-23/h3-6,11-12H,1-2,7-10H2,(H4,18,19,22)
PDB
MMDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem

Similars
Article
PubMed
n/an/a 5.10E+3n/an/an/an/an/an/a



Drug Discovery Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 305-8585, Japan. Electronic address: susumu.yamaki@astellas.com.

Curated by ChEMBL


Assay Description
Inhibition of human VAP-1 expressed in CHO cells preincubated for 20 mins followed by [14C]-benzylamine addition measured after 1 hr by scintillation...

Bioorg Med Chem 25: 6024-6038 (2017)


Article DOI: 10.1016/j.bmc.2017.09.036
BindingDB Entry DOI: 10.7270/Q2B27XR3
More data for this
Ligand-Target Pair